Supernus Pharmaceuticals, Inc. (SUPN)
46.50
+0.34
(+0.73%)
USD |
NASDAQ |
Dec 11, 16:00
46.50
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Free Cash Flow: 70.75M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.262B |
| BridgeBio Pharma, Inc. | -597.61M |
| CorMedix, Inc. | 74.42M |
| Assembly Biosciences, Inc. | -55.78M |
| Viking Therapeutics, Inc. | -224.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -61.66M |
| Cash from Investing (Quarterly) | 48.71M |
| Cash from Financing (Quarterly) | 21.07M |
| Free Cash Flow Per Share (Quarterly) | -1.093 |
| Free Cash Flow to Equity (Quarterly) | -72.23M |
| Free Cash Flow to Firm (Quarterly) | -61.79M |
| Free Cash Flow Yield | 2.70% |